Your session is about to expire
← Back to Search
15mg T3D-959 for Alzheimer's Disease
Study Summary
This trial is testing a new drug to see if it is safe and effective in improving Alzheimer's symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA ratified 15mg T3D-959 for medical use?
"Based on the available data, our team has assigned 15mg T3D-959 a safety rating of 2. This assessment is due to it being in Phase 2 clinical trials - there are some findings that suggest its security but none supporting efficacy."
Are there vacancies in the current clinical trial that could be filled by applicants?
"Clinicaltrials.gov has officially noted that this investigation, which was originally advertised on March 1st 2021 before being modified most recently on July 27th 2022, is presently not accepting patients into the trial. Nevertheless, there are 546 other studies actively recruiting individuals at this moment in time."
Do I qualify to participate in this medical experiment?
"This clinical trial seeks to enrol 256 individuals with Alzheimer's disease between the ages of 50 and 90. To be accepted, applicants must meet certain criteria including a Clinical Dementia Rating score ranging from 0.5 - 2.0, have an identified adult caregiver who can provide reliable information regarding the subject's cognition, function and behaviour on a daily basis throughout the duration of the study, as well as having mild-to-moderate cognitive impairment based upon their Mini Mental State Examination (MMSE) score at screening which should fall within 14 - 26 range."
What is the geographical scope of this experiment's implementation?
"Patients can be enrolled in this trial at Community Hospital of Anderson and Madison County Inc. in Anderson, Indiana, ANI Neurology, PLLC dba Alzheimer's Memory Center in Charlotte, North carolina, Las Vegas Medical Research in Las Vegas Nevada as well as other 38 sites."
Is this investigation recruiting participants aged less than 55 years?
"As specified in the trial's selection guidelines, patients between 50 and 90 years old are eligible to participate."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger